IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CHIODELLI, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.148
EU - Europa 1.946
AS - Asia 1.705
SA - Sud America 349
AF - Africa 33
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.210
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.085
PL - Polonia 946
SG - Singapore 629
CN - Cina 512
BR - Brasile 285
UA - Ucraina 204
DE - Germania 162
VN - Vietnam 161
HK - Hong Kong 155
IT - Italia 155
FI - Finlandia 109
FR - Francia 78
GB - Regno Unito 73
TR - Turchia 58
IE - Irlanda 43
RU - Federazione Russa 40
IN - India 39
BD - Bangladesh 30
CA - Canada 30
AU - Australia 27
AR - Argentina 26
ID - Indonesia 22
JP - Giappone 20
SE - Svezia 20
AT - Austria 18
BE - Belgio 18
CZ - Repubblica Ceca 17
MX - Messico 16
ES - Italia 14
NL - Olanda 14
ZA - Sudafrica 13
VE - Venezuela 10
IQ - Iraq 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
LT - Lituania 8
PK - Pakistan 8
EC - Ecuador 7
MA - Marocco 7
AZ - Azerbaigian 6
JO - Giordania 6
SA - Arabia Saudita 6
IL - Israele 5
PA - Panama 5
PT - Portogallo 5
UZ - Uzbekistan 4
CH - Svizzera 3
CR - Costa Rica 3
CY - Cipro 3
EE - Estonia 3
IR - Iran 3
KZ - Kazakistan 3
NG - Nigeria 3
PE - Perù 3
PY - Paraguay 3
RO - Romania 3
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
CO - Colombia 2
ET - Etiopia 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PH - Filippine 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KI - Kiribati 1
LU - Lussemburgo 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 7.210
Salva come PNG Salva come JPEG
Città #
Warsaw 944
Ashburn 350
Fairfield 313
Singapore 313
Woodbridge 180
Hong Kong 154
Houston 154
Jacksonville 149
Chandler 139
Cambridge 131
San Jose 121
Ann Arbor 120
Seattle 117
Beijing 112
Wilmington 107
The Dalles 87
New York 86
Princeton 80
Helsinki 75
Los Angeles 75
Brescia 64
Dallas 63
Munich 56
Nanjing 45
Council Bluffs 44
Ho Chi Minh City 43
Dong Ket 40
Dublin 40
Lauterbourg 40
Istanbul 39
Dearborn 37
São Paulo 35
Hanoi 25
San Francisco 25
Shanghai 24
Buffalo 23
Chicago 21
San Diego 19
Tokyo 19
Brussels 18
Phoenix 18
Redondo Beach 18
Jakarta 17
Des Moines 16
Jinan 16
Milan 16
Turku 16
London 15
Nuremberg 15
Hebei 14
Stockholm 14
Brooklyn 13
Hangzhou 13
Orem 13
Denver 12
Montreal 12
Moscow 12
Nanchang 12
Santa Clara 12
Jiaxing 11
Tianjin 11
Atlanta 10
Changsha 10
Guangzhou 10
Johannesburg 10
Brno 9
Leawood 9
Zhengzhou 9
Amsterdam 8
Ankara 8
Chennai 8
Dhaka 8
Frankfurt am Main 8
Kocaeli 8
Shenyang 8
Vienna 8
Haikou 7
Poplar 7
Rio de Janeiro 7
Baku 6
Boardman 6
Mexico City 6
Ningbo 6
Prague 6
Redwood City 6
Salt Lake City 6
Taizhou 6
Turin 6
Amman 5
Belo Horizonte 5
Charlotte 5
Curitiba 5
Kunming 5
Lancaster 5
Manchester 5
Mumbai 5
Paris 5
San Mateo 5
Toronto 5
Vancouver 5
Totale 5.089
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 360
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 315
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 305
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 299
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 272
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 266
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 249
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 228
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 213
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 187
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 185
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 184
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 177
Sialic acid as a target for the development of novel antiangiogenic strategies 173
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 167
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 163
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 159
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 151
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 146
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 144
Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway 144
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 137
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 134
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 131
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 131
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 128
Sphingosine-1-phosphate receptor1 (S1P1) regulates venous vascular permeability via EphB4 receptor 118
Long-pentraxin 3 affects primary cilium in zebrafish embryo and cancer cells via the fgf system 114
Polyanionic drugs and viral oncogenesis: a novel approach to control virus infection, tumor-associated inflammation and angiogenesis 112
Heparan-sulfate proteoglycans mediate the angiogenic activity of the novel VEGFR2 agonist gremlin 111
Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines 107
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 105
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer 99
Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma 96
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 95
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin 93
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells 91
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration 88
BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF THE INTERACTION OF GREMLIN (Drm) WITH HEPARIN/HEPARAN SULFATE PROTEOGLYCANS 86
Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis 85
HIV-1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension of its biological functions 82
implementation of a new computational protocol based on incremental docking to study interaction of long sugar chain with proteins: heparin/HIV-1 p17 case study 77
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 74
Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase 68
Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice 67
HIV-1 Tat and heparan sulfate proteoglycans orchestrate the setup of in cis and in trans cells surface interactions functional to lymphocyte trans-endothelial migration 64
Dataset: Impact of β-Galactosylceramidase Overexpression on the Protein Profile of Braf(V600E) Mutated Melanoma Cells 61
HIV-of its biological functions1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension 60
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 59
implementation of an incremental docking method to study long sugar chains interactions with proteins 58
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 56
direct inhibition of the VEGF/VEGFR system by the Eph/Ephrin antagonist UniPR1331: a new dual-acting antiangiogenic compound 49
Totale 7.323
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.039
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021246 0 0 0 0 0 0 0 0 0 91 101 54
2021/2022385 31 65 11 11 4 20 29 23 27 41 29 94
2022/2023391 52 8 20 16 32 96 5 42 62 2 32 24
2023/2024416 23 9 42 22 13 74 14 24 88 27 24 56
2024/20251.052 17 7 6 130 73 89 62 59 78 106 247 178
2025/20262.128 202 278 183 344 247 205 278 90 165 136 0 0
Totale 7.323